M K Proteins Limited

Margin compression: Operating margin fell from 6.62% (Sep 2024) to 2.19% (Jun 2026), a 68% decline in profitability.

Valuation disconnect: PE ratio of 32.83 against ROE of 9.37% suggests elevated valuation without earnings support.

Revenue volatility: Quarterly revenues swing from ₹32.43 Cr (Sep 2025) to ₹145.94 Cr (Mar 2026), suggesting strong seasonality — verify how this impacts working capital and cash flow management.

Stock performance: 1-year return of -38.66% reflects investor concern — verify whether this reflects temporary sentiment or deteriorating fundamentals.

December quarter grew 126% year-over-year (₹39.48 Cr to ₹89.56 Cr) — verify if this growth is sustainable and whether margins can recover from current 2.19%.

Moderate leverage (D/E 0.47) provides debt capacity — verify if management plans capacity expansion or will prioritize debt reduction.

Revenue stabilized at ₹115–146 Cr range (Dec 2025–Mar 2026) after September trough (₹32.43 Cr) — verify if operations have recovered and what market conditions underpin this.